TuHURA Biosciences, Inc.(HURA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | Hoffman Robert E. President and CEO | Purchase | +55,000 | +100.00%55,000 | $0.47 | $25,795 | View SEC filing | |
| 2021-12-09 | Praill Anthony Scott Chief Financial Officer | Purchase | +28,700 | +338.20%37,186 | $0.68 | $19,430 | View SEC filing | |
| 2021-12-08 | Zarrabian Saiid Head of Strategic Partnerships | Purchase | +50,000 | +821.02%56,090 | $0.63 | $31,316 | View SEC filing | |
| 2021-11-24 | Johnson Laura L. Director | Purchase | +3,000 | +100.00%3,000 | $0.74 | $2,227 | View SEC filing | |
| 2020-08-21 | Liatos John SVP, Business Development | Purchase | +196,750 | +100.00%196,750 | N/A | N/A | View SEC filing | |
| 2020-08-21 | Murphy Keith Director | Purchase | +181,010 | +100.00%181,010 | N/A | N/A | View SEC filing | |
| 2019-09-19 | Bell John K Director | Purchase | +35,000 | +100.00%35,000 | $0.68 | $23,744 | View SEC filing | |
| 2019-09-16 | Bell John K Director | Purchase | +35,000 | +360.79%44,701 | $0.68 | $23,744 | View SEC filing | |
| 2017-11-17 | Bell John K Director | Purchase | +20,000 | +26.66%95,019 | $0.81 | $16,200 | View SEC filing | |
| 2017-11-16 | Zarrabian Saiid Interim CEO | Purchase | +60,900 | +100.00%60,900 | $0.82 | $50,056 | View SEC filing | |
| 2017-10-10 | BACHA JEFFREY CEO | Purchase | +10,000 | +18.62%63,697 | $0.87 | $8,725 | View SEC filing | |
| 2017-10-05 | Praill Scott Chief Financial Officer | Purchase | +17,500 | +58.60%47,366 | $0.85 | $14,910 | View SEC filing | |
| 2017-06-28 | Praill Scott Chief Financial Officer | Purchase | +4,167 | +16.49%29,444 | $3.60 | $15,001 | View SEC filing | |
| 2017-06-28 | Mohr Erich Director | Purchase | +4,167 | +214.46%6,110 | $3.60 | $15,001 | View SEC filing | |
| 2017-06-28 | Cranston Lynda Sarah Director | Purchase | +2,083 | +798.08%2,344 | $3.60 | $7,499 | View SEC filing | |
| 2017-06-28 | Bell John K Director | Purchase | +4,167 | +9.20%49,455 | $3.60 | $15,001 | View SEC filing | |
| 2017-06-28 | BACHA JEFFREY CEO | Purchase | +6,700 | +14.36%53,345 | $3.60 | $24,120 | View SEC filing | |
| 2017-06-07 | Bell John K Director | Purchase | +10,000 | +28.34%45,288 | $2.12 | $21,200 | View SEC filing | |
| 2017-06-06 | Praill Scott Chief Financial Officer | Purchase | +9,500 | +60.21%25,277 | $2.10 | $19,950 | View SEC filing | |
| 2017-06-06 | BACHA JEFFREY CEO | Purchase | +5,000 | +12.01%46,645 | $2.12 | $10,600 | View SEC filing | |
| 2017-05-08 | BACHA JEFFREY Chief Executive Officer | Purchase | +2,500 | +6.39%41,645 | $2.20 | $5,500 | View SEC filing | |
| 2017-02-02 | BACHA JEFFREY CEO | Purchase | +4,000 | +11.44%38,969 | $5.00 | $20,000 | View SEC filing | |
| 2016-05-03 | TOTH ROBERT JOSEPH JR Director | Purchase | +13,000 | +100.00%13,000 | $0.80 | $10,400 | View SEC filing | |
| 2016-05-03 | Praill Scott Chief Financial Officer | Purchase | +37,500 | +100.00%37,500 | $0.80 | $30,000 | View SEC filing | |
| 2016-05-03 | Mohr Erich Director | Purchase | +93,750 | +100.00%93,750 | $0.80 | $75,000 | View SEC filing |
1-25 of 62